Search

everythinglearnresearchcommunity

for

Search:↓

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Minoxidil with Korean red ginseng improves hair density and thickness more than minoxidil alone.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Women with acne have lower levels of a specific hormone marker than women without acne.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Teratoma hair is similar to scalp hair but has a rougher surface and lower adhesive force.

Laser laparoscopy effectively reduces pelvic pain in women with mild to moderate endometriosis and is safe to use.

PCOS is a complex condition linked to hormonal imbalance and insulin resistance, with weight loss being important for management.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.